A Study to See How Safe a New Medicine (NNC0642-1895) is in Healthy People

Inclusion Criteria

• Male or female (sex assigned at birth, inclusive of all gender identities).
• Age 18-55 years (both inclusive) at the time of signing the informed consent.
• Body Mass Index (BMI) between 18.5 to 29.9 kilogram per square meter (kg/m\^2) (both inclusive) at screening
• Considered to be generally healthy based on the medical history, physical examination, and the results of vital signs, electrocardiogram and clinical laboratory tests performed during the screening visit, as judged by the investigator.

Exclusion Criteria

• Known or suspected hypersensitivity to study intervention(s) or related products.
• Any laboratory safety parameters at screening outside the below laboratory ranges, see designated reference range documents for specific values:

• Alanine aminotransferase (ALT) greater than (>) Upper limit of normal (ULN) +10 percent (%)
• Aspartate aminotransferase (AST) > ULN +20%
• Bilirubin > ULN +20%
• Creatinine > ULN +10%
• Absolute neutrophil count > ULN
• Absolute neutrophil count less than (\<) Lower limit of normal (LLN)
• Platelet count > ULN
• Platelet count \< LLN
• Supine blood pressure at screening outside the range of 90-139 millimeters of mercury (mmHg) for systolic or 50-89 mmHg for diastolic
• Heart rate outside the range of 50-90 beats/min at screening
• Use of prescription (except contraceptives) or non-prescription medicinal products within 14 days before screening. Occasional use of over-the-counter acetaminophen or Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) at their labelled doses is permitted.